Genetic Signatures, Microba Life Sciences in preliminary merger talks
SYDNEY: Genetic Signatures Limited and Microba Life Sciences Limited are in preliminary discussions about a potential merger that would create a leading infectious disease diagnostics group, the companies announced Wednesday. The proposed combination would unite Genetic Signatures’ regulatory-approved infectious disease panels with Microba’s microbiome profiling technology, offering a full spectrum of diagnostic testing from rapid…